Anebulo Pharmaceuticals Inc Selling, General, and Administrative Expenses (SG&A) 3 year CAGR is 66.33% for the year ending December 31, 2023, a -85.24% change year over year. Selling, General, and Administrative Expenses (SG&A) consit of the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.